These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 9549805)
1. Quality of life as an endpoint in EORTC clinical trials. European Organization for Research and Treatment for Cancer. Kiebert GM; Curran D; Aaronson NK Stat Med; 1998 Mar 15-Apr 15; 17(5-7):561-9. PubMed ID: 9549805 [TBL] [Abstract][Full Text] [Related]
2. Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions. Hahn EA; Webster KA; Cella D; Fairclough DL Stat Med; 1998 Mar 15-Apr 15; 17(5-7):547-59. PubMed ID: 9549804 [TBL] [Abstract][Full Text] [Related]
3. The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials. Bottomley A; Vanvoorden V; Flechtner H; Therasse P; Eur J Cancer; 2003 Feb; 39(3):275-85. PubMed ID: 12565977 [TBL] [Abstract][Full Text] [Related]
4. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group. Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255 [TBL] [Abstract][Full Text] [Related]
5. Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research. Bernhard J; Gusset H; Hürny C Stat Med; 1998 Mar 15-Apr 15; 17(5-7):633-9. PubMed ID: 9549812 [TBL] [Abstract][Full Text] [Related]
6. Ensuring the quality of quality of life data: the Southwest Oncology Group experience. Moinpour CM; Lovato LC Stat Med; 1998 Mar 15-Apr 15; 17(5-7):641-51. PubMed ID: 9549813 [TBL] [Abstract][Full Text] [Related]
7. The multi-centre assessment of quality of life: the Interdisciplinary Group for Cancer Care Evaluation (GIVIO) experience in Italy. Mosconi P; Torri V; Cifani S; Ruggiata R; Meyerowitz BE; Apolone G; Liberati A Stat Med; 1998 Mar 15-Apr 15; 17(5-7):577-85. PubMed ID: 9549807 [TBL] [Abstract][Full Text] [Related]
8. Compliance with QOL assessment in multi-centre German breast cancer trials. Olschewski M Stat Med; 1998 Mar 15-Apr 15; 17(5-7):571-5. PubMed ID: 9549806 [TBL] [Abstract][Full Text] [Related]
9. Quality of life in clinical cancer trials: experience and perspective of the European Organization for Research and Treatment of Cancer. Kiebert GM; Kaasa S J Natl Cancer Inst Monogr; 1996; (20):91-5. PubMed ID: 8750477 [No Abstract] [Full Text] [Related]
10. Compliance issues in quality of life assessment: experiences of two Cancer Research Campaign sponsored groups. Fallowfield L Stat Med; 1998 Mar 15-Apr 15; 17(5-7):541-6. PubMed ID: 9549803 [No Abstract] [Full Text] [Related]
11. Collecting quality of life data in EORTC clinical trials--what happens in practice? Young T; Maher J Psychooncology; 1999; 8(3):260-3. PubMed ID: 10390738 [TBL] [Abstract][Full Text] [Related]
12. Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data. Bernhard J; Peterson HF; Coates AS; Gusset H; Isley M; Hinkle R; Gelber RD; Castiglione-Gertsch M; Hürny C Stat Med; 1998 Mar 15-Apr 15; 17(5-7):587-601. PubMed ID: 9549808 [TBL] [Abstract][Full Text] [Related]
13. United Kingdom Cancer Research Campaign approach to quality-of-life research in cancer clinical trials. Hopwood P J Natl Cancer Inst Monogr; 1996; (20):103-5. PubMed ID: 8750479 [TBL] [Abstract][Full Text] [Related]
15. Missing quality of life data in cancer clinical trials: serious problems and challenges. Bernhard J; Cella DF; Coates AS; Fallowfield L; Ganz PA; Moinpour CM; Mosconi P; Osoba D; Simes J; Hürny C Stat Med; 1998 Mar 15-Apr 15; 17(5-7):517-32. PubMed ID: 9549801 [TBL] [Abstract][Full Text] [Related]
16. Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office. Fayers PM; Hopwood P; Harvey A; Girling DJ; Machin D; Stephens R Eur J Cancer; 1997 Jan; 33(1):20-8. PubMed ID: 9071894 [TBL] [Abstract][Full Text] [Related]
17. Why are missing quality of life data a problem in clinical trials of cancer therapy? Fairclough DL; Peterson HF; Chang V Stat Med; 1998 Mar 15-Apr 15; 17(5-7):667-77. PubMed ID: 9549815 [TBL] [Abstract][Full Text] [Related]
18. Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group. Osoba D; Dancey J; Zee B; Myles J; Pater J J Natl Cancer Inst Monogr; 1996; (20):107-11. PubMed ID: 8750480 [TBL] [Abstract][Full Text] [Related]
19. Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities. van Leeuwen M; Efficace F; Fosså SD; Bolla M; De Giorgi U; de Wit R; Holzner B; van de Poll-Franse LV; van Poppel H; White J; Collette L; Osanto S; Aaronson NK; ; ; Eur J Cancer; 2014 Jul; 50(11):1957-63. PubMed ID: 24820932 [TBL] [Abstract][Full Text] [Related]
20. Phase II trials in the EORTC. The Protocol Review Committee, the Data Center, the Research and Treatment Division, and the New Drug Development Office. European Organization for Research and Treatment of Cancer. Eur J Cancer; 1997 Aug; 33(9):1361-3. PubMed ID: 9337674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]